Palvella Therapeutics, Inc. (PVLA) Insider Ownership

Based on data from the past 90 days ending February 10, 2026, Palvella Therapeutics's three largest insider shareholders are Director George M Jenkins (196.69K shares), Other Partners L P/Il Bvf (38.96K shares), TenPercentOwner Capital Management, Llc Adar1 (15.07K shares).

• Palvella Therapeutics, Inc. (PVLA) exhibits a conventional ownership structure with institutions commanding 77.40% of outstanding shares, insider ownership remaining at 2.28%, and public/other investors holding 20.32%.
• As of February 10, 2026, insider ownership at Palvella Therapeutics represents 2.28% of the company's total outstanding shares, comprising approximately 251.10K shares out of 11.01Mn outstanding shares.
• Throughout the 90-day span concluding February 10, 2026, Palvella Therapeutics's insider stake decreased 15.47%, as collective insider positions declining from 297.04K shares to 251.10K shares.
• As of February 10, 2026, Chief Operating Officer Kathleen Goin emerged as Palvella Therapeutics's top insider buyer over the preceding 90 days, securing 12.91K shares.
• As of February 10, 2026, Chief Operating Officer Kathleen Goin recorded the highest insider sale volume at Palvella Therapeutics, offloading 12.91K shares during the preceding 90-day window.